Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
Eddy Pérez-Then(Higher University of San Andrés), Akiko Iwasaki(Yale University), Kendall Billig(Yale University), Nathan D. Grubaugh(Yale University), Albert I. Ko(Yale University), Emily Gagnon(United States Department of State), Chantal B. F. Vogels(Yale University), Randy Downing(United States Department of State), Marija Miric, Valter Silva Monteiro(Yale University), Margarita De los Santos(Profamilia), Amyn A. Malik(Indus Hospital), Claire Pearson(United States Department of State), Melissa Campbell(Yale University), Elena De la Cruz(Profamilia), İnci Yıldırım(Emory University), Saad B. Omer(The University of Texas Southwestern Medical Center), Mallery I. Breban(Yale University), Leila Cochón(Profamilia), Carolina Lucas(Yale University), Vivian Brache(Profamilia), Patricia de León(Instituto Tecnológico de Santo Domingo), Aidelis Jorge(Profamilia), Anthony Muyombwe(United States Department of State), Jafar Razeq(United States Department of State), Sten H. Vermund(University of South Florida)
Cited by 418
Related Papers
Microbiota regulates immune defense against respiratory tract influenza A virus infection
|Proceedings of the National Academy of Sciences|2011|1.5k